Scotts Miracle-Gro (SMG) is stepping up its SMG 2.0 shift with a new executive vice president and chief brand officer, Nick Miaritis, along with an expanded AI-enabled Kinaxis partnership to tighten supply chain planning.

Scotts Miracle-Gro’s recent leadership and supply chain moves come as the stock shows a mixed picture, with a 9.35% 1-month share price return and share price performance over the past 90 days declining 3.22%. Over longer horizons, the total shareholder return is 6.48% over 1 year and 27.86% over 3 years, while the 5-year total shareholder return is down 59.11%. This helps explain why investors are closely weighing whether the SMG 2.0 plan and AI-enabled execution can shift sentiment.

If this kind of repositioning story interests you, it can be useful to scan for other companies at turning points and see what stands out in the 20 top founder-led companies

With Scotts Miracle-Gro trading at US$64.69, sitting at a reported 17% discount to one intrinsic estimate and 12% below the average analyst target, is there still a mispricing here, or is the market already baking in SMG 2.0’s ambitions?

Most Popular Narrative: 48.7% Overvalued

According to the most followed narrative, Scotts Miracle-Gro’s fair value of $43.49 sits well below the last close at $64.69, which puts a spotlight on the assumptions behind that gap.

SMG’s current valuation reflects lingering skepticism: concerns over cannabis demand, consumer spending softness, and execution risk. However, it may also underappreciate the company’s positioning within professional cultivation.

This is not a hypergrowth story. It is a durability story. As food security, indoor agriculture, and yield efficiency gain importance globally, companies with cultivation expertise stand to benefit quietly rather than explosively.

To understand why this narrative pins Scotts Miracle-Gro’s value well below today’s share price, it focuses on a specific earnings path, measured revenue expansion, and firm profit margins that carry significant weight behind that $43.49 figure.

Result: Fair Value of $43.49 (OVERVALUED)

However, Scotts Miracle-Gro's cultivation edge could be tested if cannabis demand weakens further or professional growers shift to lower cost, unbranded inputs.

Another View on Scotts Miracle-Gro’s Valuation

That $43.49 fair value suggests Scotts Miracle-Gro is 48.7% overvalued, but the picture changes when you look at the P/E. At 18.3x, SMG trades well below the US Chemicals industry at 26.5x and far under peers at 51.5x, and almost in line with a fair ratio of 18.5x. For investors, that gap raises a simple question: is the crowd leaning too hard on one narrative while ignoring how the market often drifts toward that fair ratio over time?

Next Steps

With sentiment on Scotts Miracle-Gro split between concern and optimism, it makes sense to review the data yourself and move quickly to form your own stance using the 5 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Scotts Miracle-Gro?

If Scotts Miracle-Gro has you thinking about what else is out there, do not stop with just one stock when a wider opportunity set is a click away.

• Zero in on potential mispricings by reviewing companies that show strong fundamentals and attractive valuations in the 45 high quality undervalued stocks.
• Strengthen your income focus by scanning stocks that combine higher yields with resilience in the 8 dividend fortresses.
• Dial down risk by checking companies that aim for steadier performance in the 66 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.